Density-dependent resistance protects <i>Legionella pneumophila</i> from its own antimicrobial metabolite, HGA.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31134893.
- Also identified by DOI 10.7554/eLife.46086 and PMC identifier 6598767.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
To persist in microbial communities, the bacterial pathogen <i>Legionella pneumophila</i> must withstand competition from neighboring bacteria. Here, we find that <i>L. pneumophila</i> can antagonize the growth of other <i>Legionella</i> species using a secreted inhibitor: HGA (homogentisic acid). Unexpectedly, <i>L. pneumophila</i> can itself be inhibited by HGA secreted from neighboring, isogenic strains. Our genetic approaches further identify <i>lpg1681</i> as a gene that modulates <i>L. pneumophila</i> susceptibility to HGA. We find that <i>L. pneumophila</i> sensitivity to HGA is density-dependent and cell intrinsic. Resistance is not mediated by the stringent response nor the previously described <i>Legionella</i> quorum-sensing pathway. Instead, <i>L. pneumophila</i> cells secrete HGA only when they are conditionally HGA-resistant, which allows these bacteria to produce a potentially self-toxic molecule while restricting the opportunity for self-harm. We propose that established <i>Legionella</i> communities may deploy molecules such as HGA as an unusual public good that can protect against invasion by low-density competitors.
Medical subject headings
- Anti-Bacterial Agents
- Drug Resistance, Bacterial
- Homogentisic Acid
- Legionella pneumophila